Results 221 to 230 of about 283,224 (387)

The Effect of 5-Fluorouracil on Chloroplast Development in Euglena

, 1962
William Evans, Robert M. Smillie
openalex   +2 more sources

Effects of 5-fluorouracil on the cell kinetic and growth parameters of hepatoma 3924A [PDF]

, 1975
C. J. Kovacs, Harold A. Hopkins, Richard Simon, William B. Looney   +3 more
openalex   +1 more source

First‐Line Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective, Multicenter, Real‐World Study

Head &Neck, EarlyView.
ABSTRACT Background In Europe, pembrolizumab with or without chemotherapy is the recommended first‐line treatment for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC), with a combined positive score (CPS) ≥ 1. In France, the TPExtreme (TPEx) regimen is preferred for CPS < 1.
Alizée Simon, Cyril Abdeddaim, DucTrung Nguyen, Patrice Gallet, Didier Peiffert, Aurélien Lambert, Lionnel Geoffrois   +6 more
wiley   +1 more source

Metabolic studies of 5-fluorouracil—II. Influences of the route of administration on the dynamics of distribution in man [PDF]

, 1974
H. O. Douglass, A Mittelman
openalex   +1 more source

Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen.

Journal of Clinical Oncology, 2012
E. Van Cutsem, J. Tabernero, R. Lakomý, H. Prenen, J. Prausová, T. Macarulla, P. Ruff, G. V. van Hazel, V. Moiseyenko, D. Ferry, J. Mckendrick, J. Polikoff, A. Tellier, R. Castan, C. Allegra   +14 more
semanticscholar   +1 more source

Prophylactic Versus Reactive (PvR) Feeding in Patients Undergoing (Chemo)radiation in Head and Neck Cancers: Results of a Phase III Randomized Controlled Trial

Head &Neck, EarlyView.
ABSTRACT Background Optimal feeding strategy (Prophylactic vs. Reactive) during Radiation Therapy (RT) for Head and Neck Cancers (HNC) remains to be established. Methods This phase III trial randomized (1:1) patients of HNC to prophylactic [nasogastric tube (NGT) placed at least 1 day before RT starting] versus reactive arm (NGT when required).
Sarbani Ghosh Laskar, Shwetabh Sinha, Meenakshi Jeeva, Meetakshi Gupta, Shreyasee Karmakar, Anuj Kumar, Samarpita Mohanty, Purabi Mahajan, Shivashankar Timmanpyati, Arun Balaji, Ashwini Budrukkar, Monali Swain, Faizalam Khan, Gouri Pantvaidya, Anuja Deshmukh, Deepa Nair, Devendra Chaukar, Prathamesh Pai, Shiva Thiagarajan, Richa Vaish, Vidisha Tuljapurkar, Pankaj Chaturvedi   +21 more
wiley   +1 more source

A Forty-Three-Year-Old Male With Penile and Cavernous Metastases From Rectal Cancer. [PDF]

J Med Cases
Quannouni El Moumouhi D, Calleja Duran I, Hernandez Sanchez JE.   +2 more
europepmc   +1 more source

Interstitial fibrosis in a patient treated with 5-fluorouracil and mitomycin C. [PDF]

, 1979
J W L Fielding, J. Crocker, Rob Stockley, V S Brookes   +3 more
openalex   +1 more source

CRISPR Screens Identify PIK3C2A as a Novel Mediator of EGFR Inhibitor Resistance in Head and Neck Squamous Cell Carcinoma

Head &Neck, EarlyView.
ABSTRACT Background Head and neck squamous cell carcinoma (HNSCC) is a malignancy with poor prognosis and survival. While epidermal growth factor receptor (EGFR) is a known driver of HNSCC, EGFR inhibitors show limited efficacy as monotherapies, suggesting that effective combination therapies are needed.
Jiayu Wang, Megan L. Ludwig, Aditi Kulkarni, Andrew C. Birkeland, Nicole L. Michmerhuizen, Elizabeth Gensterblum‐Miller, Jingyi Zhai, Hui Jiang, Paul Swiecicki, Marisa Buchakjian, Molly Heft Neal, Steven B. Chinn, Matthew E. Spector, J. Chad Brenner   +13 more
wiley   +1 more source

Wumei Pills enhance intestinal stem cell - mediated repair in chemotherapy-induced mucositis <i>via Lactobacillus reuteri</i> - dependent modulation of the gut microbiota. [PDF]

World J Stem Cells
Lu DX, Wang ZX, Liu XM, Wu H, Ji LJ, Yan J.   +5 more
europepmc   +1 more source